|
Isosorbide Dinitrate Extended-Release Capsules
» Isosorbide Dinitrate Extended-Release Capsules contain not less than 90.0 percent and not more than 110.0 percent of the labeled amount of C6H8N2O8.
Packaging and storage
Preserve in well-closed containers.
Identification
The finely powdered contents of the Capsules respond to the Identification test under Isosorbide Dinitrate Tablets. If separation of interferences is required, transfer a quantity of the finely powdered contents of the Capsules, equivalent to about 20 mg of isosorbide dinitrate, to a glass-stoppered centrifuge tube, add 10 mL of sodium hydroxide solution (1 in 250), shake to wet the powder, add 15 mL of solvent hexane, and shake again. Centrifuge the mixture, and transfer the upper phase to a beaker. Place in a freezer, at a temperature of about
Dissolution
Apparatus 2:
50 rpm.
Times:
2, 4, and 8 hours.
Determine the amount of C6H8N2O8 dissolved employing the following method.
Mobile phase
Prepare a filtered and degassed mixture of 0.05 M monobasic potassium phosphate and acetonitrile (52:48). Make adjustments, if necessary (see System Suitability under Chromatography
Chromatographic system
(see Chromatography
Procedure
Separately inject equal volumes (about 20 µL) of a filtered portion of the solution under test, and record the chromatograms. Determine the amount of C6H8N2O8 dissolved in comparison with a Standard solution of USP Diluted Isosorbide Dinitrate RS in the same medium and similarly chromatographed.
Tolerances
The percentages of the labeled amount of C6H8N2O8 dissolved at the times specified conform to Acceptance Table 2. [noteThe test times given are cumulative, beginning with the 1 hour in the acid medium. ]
Uniformity of dosage units
Assay
Buffer solution
, Mobile phase, Internal standard solution, Standard preparation, and Chromatographic systemPrepare as directed in the Assay under Diluted Isosorbide Dinitrate.
Assay preparation
Weigh and finely powder the contents of not fewer than 20 Capsules. Transfer an accurately weighed portion of the powder, equivalent to about 12.5 mg of isosorbide dinitrate, to a dry, 50-mL volumetric flask, add about 30 mL of Mobile phase, and shake the mixture by hand immediately, to prevent clumping. If clumping persists, disperse with the aid of sonication, or break the aggregates with a stirring rod, or warm on a steam bath while keeping the flask stoppered, or allow the flask to stand until the clumps dissipate. [noteIf clumping still continues, discard the mixture, and instead disperse an accurately weighed test portion in 15 mL of a 1 in 10 dilution of Buffer solution in water by heating on a steam bath for 1 hour with frequent shaking, then add 15 mL of methanol. ] Shake for 30 minutes. Add 8.0 mL of Internal standard solution, cool to room temperature, add 8 mL of a 1 in 10 dilution of Buffer solution in water, dilute with Mobile phase to volume, and mix. Pass a portion through a microporous membrane filter.
Procedure
Proceed as directed for Procedure in the Assay under Diluted Isosorbide Dinitrate. Calculate the quantity, in mg, of C6H8N2O8 in the portion of Capsules taken by the formula:
50C(RU / RS)
in which C is the concentration, in mg per mL, of isosorbide dinitrate from the USP Diluted Isosorbide Dinitrate RS taken for the Standard preparation; and RU and RS are the ratios of the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 3588
Pharmacopeial Forum: Volume No. 31(1) Page 160
|